Point72 Asia (Singapore)’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$58.3K	Buy	+25,252	New	+$58.3K	0.01%	566
2024 Q2	–	Sell	-181,306	Closed	-$520K	–	1495
2024 Q1	$520K	Buy	+181,306	New	+$520K	0.14%	160